|
| |
| | | 70253 | | 01.06.2026 | | MSD Merck Sharp & Dohme AG | | | | | | | 31.05.2031 | | | | | | 70000. | | | | 07.16.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Keytruda subkutan 395 mg/2.4 ml | Injektionslösung | Injection solution (Pembrolizumabum 395mg / 2.4ml) | L01FF02 | | | 02 | Keytruda subkutan 790 mg/4.8 ml | Injektionslösung | Injection solution (Pembrolizumabum 790mg / 4.8ml) | L01FF02 | |
|
|
|
